Cargando…
JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice
Multiple myeloma (MM) patients develop osteolysis characterised by excessive osteoclastic bone destruction and lack of osteoblast bone formation. Pharmacological manipulation of monoacylglycerol lipase (MAGL), an enzyme responsible for the degradation of the endocannabinoid 2-arachidonoyl glycerol (...
Autores principales: | Marino, Silvia, Carrasco, Giovana, Li, Boya, Shah, Karan M., Lath, Darren L., Sophocleous, Antonia, Lawson, Michelle A., Idris, Aymen I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271071/ https://www.ncbi.nlm.nih.gov/pubmed/32285169 http://dx.doi.org/10.1007/s00223-020-00689-0 |
Ejemplares similares
-
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice
por: Marino, Silvia, et al.
Publicado: (2019) -
Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells
por: Pihlaja, Rea, et al.
Publicado: (2015) -
Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome
por: Lysenko, Larisa V., et al.
Publicado: (2014) -
TRAF6 as a potential target in advanced breast cancer: a systematic review, meta-analysis, and bioinformatics validation
por: Zeng, Feier, et al.
Publicado: (2023) -
Antiangiogenic Action of JZL184 on Endothelial Cells via Inhibition of VEGF Expression in Hypoxic Lung Cancer Cells
por: Wittig, Felix, et al.
Publicado: (2023)